Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. appears in FDA public data with 3 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 12 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0427-2018, Class III) was initiated on February 2, 2018.
Summary
- Total Recalls
- 3 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 12
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0427-2018 | Class III | Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles, Rx Only, Manufactured for: Aurobi | February 2, 2018 |
| D-0339-2018 | Class I | Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per c | January 2, 2018 |
| D-041-2013 | Class II | Northstar Zolpidem Tartrate Tablets USP 10 mg. Manufactured for Northstar RX, LLC Memphis, TN 38141 | March 9, 2012 |